Alternative dosage of zidovudine in infants exposed to maternal human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1131-1132

  Frasca, Katherine ^a   Fisher, Randall G ^a   McGuire, Erin ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

HIV exposure; Maternal fetal HIV transmission; Zidovudine; Zidovudine dosing

Indexed keywords

ZIDOVUDINE;

ARTICLE; CLINICAL PROTOCOL; DIARRHEA; DRUG EFFICACY; FACE WEAKNESS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 74049089206     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181af59eb     Document Type: Article

References (10)

1. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovu-dine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Eng J Med. 1996;335:1621-1629.
2. Volmink J, Siegfried NL, van der Merwe L, et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007:CD003510.
3. Perinatal HIV Guidelines Working Group. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (Table 5). Rockville, MD, July 8, 2008, pp 1-98. Available at: http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf. Accessed April, 2009.
4. Sande MA, Elipoulous GM, Moellering R Jr, et al. The Sanford Guide to HIV/AIDS Therapy 2008. 16th ed. Antimicrobial Therapy; 2007:34, 45-46, 54.
5. Magder LS, Mofenson L, Paul ME, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005;38:87-95.
6. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep. 2006; 55:592-597.
7. Conway B. The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr. 2007;45(suppl 1):S14-S18.
8. McKinney RE Jr, Rodman J, Hu C, et al. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naïve children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 2007;120:e416-e423.
9. Benjamin DK Jr, Miller WC, Fiscus SA, et al. Rational testing of the HIV-Exposed infant. Pediatrics. 2001;108:E3.
10. Hanley JA, Lippman-Hand A. If nothing is wrong, is everything all right? Interpreting zero numerators. JAMA. 1983;249:1743-1745.